In this study, the intergroup comparison showed detectable and noteworthy differences in the CSF biomarkers (Aβ42, P-tau, and T-tau) between the patients with SCD and healthy individuals. The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.